Home » Open Access » IJS Oncology

IJS Oncology

Journal web site: http://journals.lww.com/ijsoncology   
Journal submission site: http://www.editorialmanager.com/ijsoncology

IJS Oncology is a peer-reviewed, international, open access journal seeking to publish in the field of broad field oncology, including surgical, medical and radiation oncology. We aim to publish basic science, clinical and translational articles.  We aim to provide rapid submission to decision times whilst maintaining a high quality peer-review process.  IJS Oncology seeks to publish the following types of articles:

About Open Access Publication

IJS Oncology is an open access, peer-reviewed journal. To provide open access, the journal charges an article processing charge (APC) for each article published. These fees cover the expenses incurred by publication, including the peer review process, journal production and publication, and hosting and archiving fees. Fees vary by article type.

Article Processing Charge (APC)

Article processing fees are charged after peer review and acceptance but prior to publication. All decisions to accept manuscripts are based solely on editorial criteria. Publication fees must be received by the publisher before an article is published. All fees and financial transactions related to article publication are conducted by the publisher, Wolters Kluwer.

The APCs for IJS Oncology are $1000 USD for Tier 1 manuscripts (Original Research Articles, Review Articles, and Experimental Research) and $400 USD for Tier 2 manuscripts (Letters and Editorials). Authors may pay by credit card or request that an invoice be sent to them, their funders, or their institutions.  Please direct any questions regarding article publication fees to: Elizabeth Durzy, Senior Publisher, Elizabeth.Durzy@wolterskluwer.com.

Open Access Copyright and License Information Attribution-NonCommercial-NoDerivs: CC BY-NC-ND.

This license is the most restrictive of the six main licenses, only allowing others to download your works and share it with others as long as they credit you, but they can’t change the work in any way or use it commercially. 

Attribution-NonCommerical-ShareAlike: CC BY-NC-SA.

This license lets others remix, tweak, and build upon your work noncommercially, as long as they credit you and license their new creations under the identical terms.

Attribution-NonCommercial: CC BY-NC.

This license lets others remix, tweak, and build upon your work noncommercially, and although their new works must also acknowledge you and be noncommercial, they don’t have to license their derivative works on the same terms.

Attribution-NoDerivs: CC BY-ND.

This license allows for redistribution, commercial and noncommercial, of your work as long as it is passed along unchanged and in whole, with credit to you.

Attribution-ShareAlike: CC BY-SA.

This license lets others remix, tweak, and build upon your work even for commercial purposes, as long as they credit you and license their new creations under the identical terms. All new works based on yours will carry the same license, so any derivatives will also allow commercial use.

Attribution: CC-BY.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. This is the most accommodating of licenses offered.

Abstracting, Indexing, and Digital Archiving

As a brand-new journal, IJS Oncology does not yet have an Impact Factor and is not yet included in PubMed Central or PubMed. As soon as the required application criteria are met, the journal will apply for indexing in these databases. When accepted, indexing will occur retroactively. Similarly, when application criteria are met, IJS Oncology will apply for an Impact Factor.

 

Wolters Kluwer Journal Brands Lippincott Williams & Wilkins | Medknow For Wolters Kluwer Contributors   Activate your book discount